Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer-Reference-Cited by-同舟云学术

Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer

Published:2023-02-13 Issue:8 Volume:128 Page:1603-1608
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Umemoto Kumiko^ORCID,Sunakawa Yu^ORCID,Ueno Makoto^ORCID,Furukawa Masayuki,Mizuno Nobumasa,Sudo Kentaro,Kawamoto Yasuyuki^ORCID,Kajiwara Takeshi^ORCID,Ohtsubo Koushiro,Okano Naohiro,Matsuhashi Nobuhisa,Itoh Shinji,Matsumoto Toshihiko,Shimizu Satoshi,Otsuru Toru,Hasegawa Hiroko,Okuyama Hiroyuki,Ohama Hideko,Moriwaki Toshikazu^ORCID,Ohta Takashi,Odegaard Justin I.,Nakamura Yoshiaki,Bando Hideaki,Yoshino Takayuki^ORCID,Ikeda Masafumi^ORCID,Morizane Chigusa

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02189-y.pdf

Reference15 articles.

1. Collins MA, Bednar F, Zhang Y, Brisset JC, Galban S, Galban CJ, et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Investig. 2012;122:639–53.

2. Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, et al. Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers. Gastroenterology. 2019;156:2242–53.e4

3. Tempero MA. NCCN guidelines updates: pancreatic cancer. J Natl Compr Cancer Netw: JNCCN. 2019;17:603–5.

4. Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9:34.

5. Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23:703–13.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients;Translational Research;2024-09

2. Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer;British Journal of Cancer;2024-08-28

3. Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come;Journal of Surgical Oncology;2024-08-19

4. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability;Annals of Surgical Oncology;2024-03-19

5. High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study;Journal of Translational Medicine;2024-02-20